Skip to main content

IDWeek 2021 Main banner

Tweets by IDWeek 2021

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Mark Moore, PhD

Gilead Sciences
Uxbridge, England, United Kingdom

Gilead Sciences (Employee)

Presentation(s):

77 - Risk of Virologic Failure Among Treatment-experienced Suppressed People with HIV (PWH) Treated with Single-Tablet 2-Drug (2DR) vs 3-Drug (3DR) Regimens

On Demand